Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Ho

Showing results (81-90 of 221) with videos related to

Pageof 23
Sort By:
Journal of Virology|January 1, 1992
Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolatesJ P Moore, J A McKeating, Y X Huang, et al.
Science (New York, N.Y.)|March 15, 1996
HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation timeA S Perelson, A U Neumann, M Markowitz, et al.
Journal of Virology|February 1, 1997
Identification of a replication-competent pathogenic human immunodeficiency virus type 1 with a duplication in the TCF-1alpha region but lacking NF-kappaB binding sitesL Zhang, Y Huang, H Yuan, et al.
European Journal of Epidemiology|June 1, 1987
Sequential changes in antibody levels to the env and gag antigens in human immunodeficiency virus infected subjectsN Manca, F di Marzo Veronese, D D Ho, et al.
Journal of Virology|September 1, 1992
Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoproteinM Thali, C Furman, D D Ho, et al.
Blood|October 1, 1989
Granulocyte- and granulocyte-macrophage colony-stimulating factors enhance neutrophil cytotoxicity toward HIV-infected cellsG C Baldwin, N D Fuller, R L Roberts, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Cooperativity of neutralizing antibodies directed against the V3 and CD4 binding regions of the human immunodeficiency virus gp120 envelope glycoproteinM Thali, C Furman, B Wahren, et al.
The American Journal of Medicine|March 1, 1989
Human immunodeficiency virus type 1 in a seronegative patient with visceral Kaposi's sarcoma and hypogammaglobulinemiaD D Ho, T Moudgil, H S Robin, et al.
AIDS (London, England)|May 1, 1992
Rapid generation of sequence variation during primary HIV-1 infectionS Pang, Y Shlesinger, E S Daar, et al.
Pediatrics|June 1, 1991
Virus burden in human immunodeficiency virus type 1-infected children: relationship to disease status and effect of antiviral therapyI Srugo, P A Brunell, N V Chelyapov, et al.
Pageof 23

Showing results (81-90 of 221) with videos related to

Sort By:
Pageof 23
Journal of Virology|January 1, 1992
Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolatesJ P Moore, J A McKeating, Y X Huang, et al.
Science (New York, N.Y.)|March 15, 1996
HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation timeA S Perelson, A U Neumann, M Markowitz, et al.
Journal of Virology|February 1, 1997
Identification of a replication-competent pathogenic human immunodeficiency virus type 1 with a duplication in the TCF-1alpha region but lacking NF-kappaB binding sitesL Zhang, Y Huang, H Yuan, et al.
European Journal of Epidemiology|June 1, 1987
Sequential changes in antibody levels to the env and gag antigens in human immunodeficiency virus infected subjectsN Manca, F di Marzo Veronese, D D Ho, et al.
Journal of Virology|September 1, 1992
Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoproteinM Thali, C Furman, D D Ho, et al.
Blood|October 1, 1989
Granulocyte- and granulocyte-macrophage colony-stimulating factors enhance neutrophil cytotoxicity toward HIV-infected cellsG C Baldwin, N D Fuller, R L Roberts, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Cooperativity of neutralizing antibodies directed against the V3 and CD4 binding regions of the human immunodeficiency virus gp120 envelope glycoproteinM Thali, C Furman, B Wahren, et al.
The American Journal of Medicine|March 1, 1989
Human immunodeficiency virus type 1 in a seronegative patient with visceral Kaposi's sarcoma and hypogammaglobulinemiaD D Ho, T Moudgil, H S Robin, et al.
AIDS (London, England)|May 1, 1992
Rapid generation of sequence variation during primary HIV-1 infectionS Pang, Y Shlesinger, E S Daar, et al.
Pediatrics|June 1, 1991
Virus burden in human immunodeficiency virus type 1-infected children: relationship to disease status and effect of antiviral therapyI Srugo, P A Brunell, N V Chelyapov, et al.
Pageof 23